Since COVID-19 struck, China has made vaccine research and development one of its major tasks, said Guo Weimin, spokesperson for the fourth session of the 13th National Committee of the Chinese People's Political Consultative Conference (CPPCC).
China has always given top priority to safety and effectiveness, he added when briefing the media on the session on Wednesday.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3